Cleared Traditional

K981114 - MICROCAP

K981114 is an FDA 510(k) clearance for MICROCAP, manufactured by Oridion Medical , Ltd.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 90-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1998
Decision
90d
Days
Class 2
Risk

K981114 is an FDA 510(k) clearance for the MICROCAP. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Oridion Medical , Ltd. (Jerusalem, IL). The FDA issued a Cleared decision on June 25, 1998 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Oridion Medical , Ltd. devices

FDA 510(k) Submission Details - K981114

510(k) Number K981114 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 27, 1998
Decision Date June 25, 1998
Days to Decision 90 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
50d faster than avg
Panel avg: 140d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 201
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K981114.
NONIN PULSE OXIMETER AND CARBON DIOXIDE DETECTOR, MODELS 9843, 9845 AND 9847
K982969 · Nonin Medical, Inc. · Aug 1999
NIHON KOHDEN TG-901T CO2 SENSOR KIT WITH ACCESSORIES
K990063 · Nihon Kohden America, Inc. · Jun 1999
CAPNOCHECK II, MODEL 8400
K991086 · Bci Intl., Inc. · Jun 1999
FUKUDA DENSHI MODEL HC-500 END TIDAL CO2 MODULE
K980979 · Fukuda Denshi USA, Inc. · Jun 1998
VACU*MED, GOLD EDITION CARBON DIOXIDE GAS ANALYZER
K973544 · Vacumed, Div. of Vacumetrics, Inc. · May 1998
TRIP TONOMETRY CATHETER, 18F
K980384 · Datex-Engstrom, Inc. · May 1998